Literature DB >> 27406189

Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.

Eva Medina1, Dietmar Helmut Pieper2.   

Abstract

With the advent of the antibiotic era, the overuse and inappropriate consumption and application of antibiotics have driven the rapid emergence of multidrug-resistant pathogens. Antimicrobial resistance increases the morbidity, mortality, length of hospitalization and healthcare costs. Among Gram-positive bacteria, Staphylococcus aureus (MRSA) and multidrug-resistant (MDR) Mycobacterium tuberculosis, and among the Gram-negative bacteria, extended-spectrum beta-lactamase (ESBLs)-producing bacteria have become a major global healthcare problem in the 21st century. The pressure to use antibiotics guarantees that the spread and prevalence of these as well as of future emerging multidrug-resistant pathogens will be a persistent phenomenon. The unfeasibility of reversing antimicrobial resistance back towards susceptibility and the critical need to treat bacterial infection in modern medicine have burdened researchers and pharmaceutical companies to develop new antimicrobials effective against these difficult-to-treat multidrug-resistant pathogens. However, it can be anticipated that antibiotic resistance will continue to develop more rapidly than new agents to treat these infections become available and a better understanding of the molecular, evolutionary and ecological mechanisms governing the spread of antibiotic resistance is needed. The only way to curb the current crisis of antimicrobial resistance will be to develop entirely novel strategies to fight these pathogens such as combining antimicrobial drugs with other agents that counteract and obstruct the antibiotic resistant mechanisms expressed by the pathogen. Furthermore, as many antibiotics are often inappropriately prescribed, a more personalized approach based on precise diagnosis tools will ensure that proper treatments can be promptly applied leading to more targeted and effective therapies. However, in more general terms, also the overall use and release of antibiotics in the environment needs to be better controlled.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27406189     DOI: 10.1007/82_2016_492

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  61 in total

Review 1.  Antibiotic Resistance Crisis: An Update on Antagonistic Interactions between Probiotics and Methicillin-Resistant Staphylococcus aureus (MRSA).

Authors:  Basavaprabhu H Nataraj; Rashmi H Mallappa
Journal:  Curr Microbiol       Date:  2021-04-21       Impact factor: 2.188

2.  Apicidin Attenuates MRSA Virulence through Quorum-Sensing Inhibition and Enhanced Host Defense.

Authors:  Corey P Parlet; Jeffrey S Kavanaugh; Heidi A Crosby; Huzefa A Raja; Tamam El-Elimat; Daniel A Todd; Cedric J Pearce; Nadja B Cech; Nicholas H Oberlies; Alexander R Horswill
Journal:  Cell Rep       Date:  2019-04-02       Impact factor: 9.423

3.  Engineered Probiotic for the Inhibition of Salmonella via Tetrathionate-Induced Production of Microcin H47.

Authors:  Jacob D Palmer; Emma Piattelli; Beth A McCormick; Mark W Silby; Christopher J Brigham; Vanni Bucci
Journal:  ACS Infect Dis       Date:  2017-09-20       Impact factor: 5.084

4.  [Treatment refractory multidrug-resistant bacterial keratitis].

Authors:  Florian Schubert; Walter Sekundo; Christoph Paul
Journal:  Ophthalmologe       Date:  2021-05       Impact factor: 1.059

5.  Caffeine-loaded gold nanoparticles: antibiofilm and anti-persister activities against pathogenic bacteria.

Authors:  Fazlurrahman Khan; Seul-Ki Park; Nilushi Indika Bamunuarachchi; DoKyung Oh; Young-Mog Kim
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-26       Impact factor: 4.813

Review 6.  Strategies for Biofilm Inhibition and Virulence Attenuation of Foodborne Pathogen-Escherichia coli O157:H7.

Authors:  Sandra Folarin Oloketuyi; Fazlurrahman Khan
Journal:  Curr Microbiol       Date:  2017-07-25       Impact factor: 2.188

7.  Synergistic action of substituted indole derivatives and clinically used antibiotics against drug-resistant bacteria.

Authors:  Danielle N Turner; Leslie Edwards; Alexander Kornienko; Liliya V Frolova; Snezna Rogelj
Journal:  Future Microbiol       Date:  2020-06-02       Impact factor: 3.165

8.  Synergistic ROS-Associated Antimicrobial Activity of Silver Nanoparticles and Gentamicin Against Staphylococcus epidermidis.

Authors:  Paulina Mazur; Iwona Skiba-Kurek; Paulina Mrowiec; Elżbieta Karczewska; Ryszard Drożdż
Journal:  Int J Nanomedicine       Date:  2020-05-19

Review 9.  Automation and data-driven design of polymer therapeutics.

Authors:  Rahul Upadhya; Shashank Kosuri; Matthew Tamasi; Travis A Meyer; Supriya Atta; Michael A Webb; Adam J Gormley
Journal:  Adv Drug Deliv Rev       Date:  2020-11-24       Impact factor: 15.470

10.  Chemical Synthesis and Structure-Activity Relationship Study Yield Desotamide a Analogues with Improved Antibacterial Activity.

Authors:  Run Xu; Yongxiang Song; Jun Li; Jianhua Ju; Qinglian Li
Journal:  Mar Drugs       Date:  2021-05-24       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.